MDPI (Multidisciplinary Digital Publishing Institute) is an academic open-access publisher with headquarters in Basel, Switzerland. Additional offices are located in Beijing and Wuhan (China) as well as in Barcelona (Spain). MDPI publishes 150 diverse peer-reviewed, scientific, open access, electronic journals.
International Journal of Molecular Sciences
International Journal of Molecular Sciences (ISSN 1422-0067; CODEN: IJMCFK; ISSN 1661-6596 for printed edition) is an open access journal providing an advanced forum for chemistry, molecular physics and molecular biology, and is published monthly online by MDPI.
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
University of Basel
The university opened with a mass held at Basel Minster on 4 April 1460. It has undergone dynamic development ever since its inception. During the first year following its founding, the University Register in Basel listed 226 students and lecturers. Today, the seven faculties at the University of Basel have around 13,000 students and over 350 professors.
Non-Coding RNA (ISSN 2311-553X) is an international open access journal on non-coding RNA research dealing with elucidationg the structure, function and biology of regulatory non-coding RNAs. ncRNA is published quarterly online by MDPI.
Arraystar uses cutting edge science, state of the art technologies, and innovative products to empower biomedical science researchers. We provide comprehensive and systematic analysis for expression profiling and for the regulation of RNAs, especially the regulatory non-coding RNAs (ncRNAs).
Basel is well known for its research and education institutions. The University of Basel, founded in 1460, provides a diverse academic environment and strives for excellence in teaching and research. The oldest university in Switzerland, it features among the 100 top-ranked institutions of higher education in the world. Its renowned Center for Molecular Life Sciences (Biozentrum) performs basic research in molecular biology that meets the highest international standards. The centre is also a supporting pillar of the national research cluster for systems biology, «SystemsX.ch». Research in medicine is a further area of strength, driven mainly by the Department of Biomedicine and the clinical research conducted at the University Hospital. The Swiss Nanoscience Institute, also affiliated with the university, has an international reputation. In a unique way, the institute links the University of Basel, the University of Applied Sciences and Arts Northwestern Switzerland and the federal Paul Scherrer Institute, thus forming a powerful and innovative network.
GATC Biotech, a family- owned business since 1990, is Europe’s leading sequencing services provider with more than 10,000 customers from academia, healthcare and industry worldwide. The company consistently contributes to the sequencing field with innovative products, scientific expertise and rigorous quality.
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective.
Exiqon operates in two business areas: Life Sciences and Diagnostics.
Exiqon is a leading supplier of flexible solutions for RNA research. Exiqon's products and services are used by researchers in academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and the development of disease. Taking advantage of our proprietary LNA™ technology, our product lines offer superior specificity and sensitivity for analysis of microRNA, mRNA and long non-coding RNA. Exiqon's products and services encompass the entire workflow from sample preparation to expression analysis (Sequencing, Array and qPCR), detection and functional analysis both in vitro and in vivo. Exiqon Services offers expertise in RNA Next Generation Sequencing, microRNA profiling and biomarker discovery from clinical samples.
Exiqon Diagnostics is pioneering the area of microRNA cancer biomarker discovery in liquid biopsies (serum, plasma and urine and other biofluids). Exiqon Diagnostics collaborates with pharmaceutical companies in their effort to develop new medicines based on non-coding and coding RNA as biological markers, and novel molecular diagnostic tests to help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.